These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

319 related items for PubMed ID: 26702935

  • 1. Naringin, a natural dietary compound, prevents intestinal tumorigenesis in Apc (Min/+) mouse model.
    Zhang YS, Li Y, Wang Y, Sun SY, Jiang T, Li C, Cui SX, Qu XJ.
    J Cancer Res Clin Oncol; 2016 May; 142(5):913-25. PubMed ID: 26702935
    [Abstract] [Full Text] [Related]

  • 2. Chemoprevention of intestinal adenomatous polyposis by acetyl-11-keto-beta-boswellic acid in APC(Min/+) mice.
    Liu HP, Gao ZH, Cui SX, Wang Y, Li BY, Lou HX, Qu XJ.
    Int J Cancer; 2013 Jun 01; 132(11):2667-81. PubMed ID: 23132636
    [Abstract] [Full Text] [Related]

  • 3. The comparative study of acetyl-11-keto-beta-boswellic acid (AKBA) and aspirin in the prevention of intestinal adenomatous polyposis in APC(Min/+) mice.
    Wang R, Wang Y, Gao Z, Qu X.
    Drug Discov Ther; 2014 Feb 01; 8(1):25-32. PubMed ID: 24647155
    [Abstract] [Full Text] [Related]

  • 4. Inhibition of intestinal adenoma formation in APC(Min/+) mice by Riccardin D, a natural product derived from liverwort plant Dumortiera hirsuta.
    Liu HP, Gao ZH, Cui SX, Sun DF, Wang Y, Zhao CR, Lou HX, Qu XJ.
    PLoS One; 2012 Feb 01; 7(3):e33243. PubMed ID: 22432006
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Chemoprevention of colon and small intestinal tumorigenesis in APC(min/+) mice by SHetA2 (NSC721689) without toxicity.
    Benbrook DM, Guruswamy S, Wang Y, Sun Z, Mohammed A, Zhang Y, Li Q, Rao CV.
    Cancer Prev Res (Phila); 2013 Sep 01; 6(9):908-16. PubMed ID: 23852423
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Aldose Reductase Inhibitor, Fidarestat Prevents High-fat Diet-induced Intestinal Polyps in ApcMin/+ Mice.
    Saxena A, Tammali R, Ramana KV, Srivastava SK.
    Curr Cancer Drug Targets; 2018 Sep 01; 18(9):905-911. PubMed ID: 28786349
    [Abstract] [Full Text] [Related]

  • 13. Improved innate immune responses by Frondanol A5, a sea cucumber extract, prevent intestinal tumorigenesis.
    Janakiram NB, Mohammed A, Bryant T, Lightfoot S, Collin PD, Steele VE, Rao CV.
    Cancer Prev Res (Phila); 2015 Apr 01; 8(4):327-37. PubMed ID: 25657017
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Chemoprevention of intestinal tumorigenesis in APCmin/+ mice by silibinin.
    Rajamanickam S, Velmurugan B, Kaur M, Singh RP, Agarwal R.
    Cancer Res; 2010 Mar 15; 70(6):2368-78. PubMed ID: 20215518
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Sunitinib malate inhibits intestinal tumor development in male ApcMin/+ mice by down-regulating inflammation-related factors with suppressing β-cateinin/c-Myc pathway and re-balancing Bcl-6 and Caspase-3.
    Chen L, Xu P, Xiao Q, Chen L, Li S, Jian JM, Zhong YB.
    Int Immunopharmacol; 2021 Jan 15; 90():107128. PubMed ID: 33191180
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Intestinal epithelial cell-specific CD98 expression regulates tumorigenesis in Apc(Min/+) mice.
    Nguyen HT, Dalmasso G, Yan Y, Laroui H, Charania M, Ingersoll S, Ayyadurai S, Zhang Y, Sitaraman S, Merlin D.
    Lab Invest; 2012 Aug 15; 92(8):1203-12. PubMed ID: 22641098
    [Abstract] [Full Text] [Related]

  • 20. Irsogladine maleate, a gastric mucosal protectant, suppresses intestinal polyp development in Apc-mutant mice.
    Onuma W, Tomono S, Miyamoto S, Fujii G, Hamoya T, Fujimoto K, Miyoshi N, Fukai F, Wakabayashi K, Mutoh M.
    Oncotarget; 2016 Feb 23; 7(8):8640-52. PubMed ID: 26840084
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.